Paper Details

  1. Home
  2. Paper Details

Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium.

Author: ChemalyRoy F, KhawajaFareed, KottonCamille N, SpalloneAmy

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

CMV infections pose a significant burden for transplant recipients, and while valganciclovir and ganciclovir have been effective, they also carry risks such as leucopenia and resistance. The development of new therapies that are both effective and well-tolerated is crucial.
Paper Details　
Original Abstract of the Article :
The burden that cytomegalovirus (CMV) portends for haematopoietic and solid-organ transplant recipients cannot be understated. Valganciclovir and ganciclovir have successfully been used for prevention and treatment of CMV infections, although with serious side effects such as leucopenia and some dev...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.cmi.2022.07.001

データ提供：米国国立医学図書館（NLM）

Cytomegalovirus Infection: New Weapons in the Fight

This research explores the ongoing challenge of cytomegalovirus (CMV) infection in transplant recipients. The study discusses the limitations of current treatment options, such as valganciclovir and ganciclovir, and highlights the need for new and effective therapies.

Fighting CMV: A Battle for Transplant Recipients

The study emphasizes the significant burden of CMV infection in transplant recipients, often leading to serious complications. The researchers underscore the need for new therapies that are effective and well-tolerated, as existing options can have serious side effects and lead to drug resistance.

The Search for Effective CMV Therapies

Imagine a world where transplant recipients are protected from CMV infection, like an oasis shielded from the harsh desert winds. This research highlights the ongoing search for effective and safe therapies to combat CMV infection. It's a testament to the dedication of researchers in finding solutions to improve the health and well-being of transplant recipients.

Dr. Camel's Conclusion

This research sheds light on the ongoing battle against CMV infection in transplant recipients. It emphasizes the urgent need for new and improved therapies that are both effective and well-tolerated. The pursuit of these therapies is a critical step towards a world where transplant recipients can thrive.

Date :
  1. Date Completed 2022-12-27
  2. Date Revised 2022-12-30
Further Info :

Pubmed ID

35843567

DOI: Digital Object Identifier

10.1016/j.cmi.2022.07.001

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.